Semler Scientific (SMLR) Stock Forecast, Price & News

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Semler Scientific in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" SMLR shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SMLR, but not buy additional shares or sell existing shares.
View SMLR analyst ratings or view top-rated stocks.

1 Wall Street analysts have issued 12 month price targets for Semler Scientific's stock. Their SMLR share price forecasts range from $45.00 to $45.00. On average, they anticipate the company's share price to reach $45.00 in the next twelve months. This suggests a possible upside of 59.9% from the stock's current price.
View analysts price targets for SMLR or view top-rated stocks among Wall Street analysts.

Semler Scientific's stock was trading at $33.00 at the beginning of 2023. Since then, SMLR shares have decreased by 14.7% and is now trading at $28.15.
View the best growth stocks for 2023 here.

Semler Scientific, Inc. (OTCMKTS:SMLR) released its quarterly earnings data on Tuesday, March, 21st. The medical equipment provider reported $0.41 EPS for the quarter. The medical equipment provider earned $13.79 million during the quarter. Semler Scientific had a net margin of 26.17% and a trailing twelve-month return on equity of 28.98%.

ETFs with the largest weight of Semler Scientific (OTCMKTS:SMLR) stock in their portfolio include Janus Henderson Small Cap Growth Alpha ETF (JSML), Janus Henderson Small/Mid Cap Growth Alpha ETF (JSMD),

Semler Scientific updated its first quarter 2023 earnings guidance on Wednesday, March, 22nd. The company provided EPS guidance of for the period. The company issued revenue guidance of $17.40 million-$17.80 million, compared to the consensus revenue estimate of $15.30 million.

Based on aggregate information from My MarketBeat watchlists, some companies that other Semler Scientific investors own include BioSpecifics Technologies (BSTC), Anavex Life Sciences (AVXL), Cornerstone OnDemand (CSOD), Innoviva (INVA), Novo Nordisk A/S (NVO), Sorrento Therapeutics (SRNE), Vertex Pharmaceuticals (VRTX), Acer Therapeutics (ACER), Allena Pharmaceuticals (ALNA) and Digital Turbine (APPS).

Semler Scientific trades on the OTCMKTS under the ticker symbol "SMLR."

Semler Scientific's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Punch & Associates Investment Management Inc. (2.27%), Avalon Investment & Advisory (1.94%), Rice Hall James & Associates LLC (1.36%), Acadian Asset Management LLC (1.16%), BlackRock Inc. (1.14%) and Empower Advisory Group LLC (0.65%). Insiders that own company stock include Douglas Murphy-Chutorian, HC Chang & Diana Sho William and Wayne T Pan.
View institutional ownership trends.

Shares of SMLR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of SMLR stock can currently be purchased for approximately $28.15.

Semler Scientific (OTCMKTS:SMLR) has a market capitalization of $192.88 million and generates $60.88 million in revenue each year. The medical equipment provider earns $14.32 million in net income (profit) each year or $2.01 on an earnings per share basis.

The company employs 124 workers across the globe.

Semler Scientific's mailing address is 911 BERN COURT SUITE 110, SAN JOSE CA, 95112. The official website for the company is www.semlerscientific.com. The medical equipment provider can be reached via phone at (877) 774-4211 or via email at susan@sanoonan.com.